adverse drug reaction Archive — Page 1 of 2

October 5, 2026

Vanderbilt Health to lead national consortium on life-threatening drug reactions of the skin

“For too long, patients who survive these reactions have been left without clear answers about why it happened, which medicines are safe, and what the future holds,” said Elizabeth Phillips, MD, who is leading the consortium.

September 2, 2026

Millions get wrong genetic test, study finds

A study shows current testing is providing false reassurance about genetic disposition for a rare life-threatening drug reaction.

April 7, 2026

AI finds drug safety signals in clinical notes

Large language models were tested on cancer patient notes from two academic medical centers and seven drug trials.

February 25, 2026

Patients with atrial fibrillation face higher bleeding risks when treated with 2 common medications

While diltiazem remains an effective option for heart rate control in selected patients, bleeding risk posed by anticoagulants should be considered.

December 11, 2024

Study uses AI to cast light on harmful drug-drug interactions

Using AI, a team identified a gap in post-market drug safety: not all published reports of dangerous drug interactions are taken up by recognized purveyors of drug safety information.

(iStock)
October 16, 2024

Study of severe drug reactions finds skin cells activate their own assassins

Single-cell analysis reveals the inner workings of the life-threatening adverse drug reactions Stevens-Johnson syndrome and toxic epidermal necrolysis.